Comparison between fluorine-18 fluorodeoxyglucose PET/CT (PET) and contrast enhancement Computed Tomography (ceCT) for staging in esophageal cancer

被引：0
|
作者：
Panareo, Stefano [1 ]
Cittanti, Corrado [1 ]
Santi, Ivan [1 ]
Peterle, Chiara [1 ]
de Cristofaro, Valentina [1 ]
Feggi, Luciano [1 ]
机构：
[1] Nucl Med Unit, Diagnost Imaging & Lab Med, Ferrara, Italy
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1401
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Impact of fluorine-18-fluorodeoxyglucose PET/computed tomography in staging of patients with gallbladder cancer: a systematic review and meta-analysis
    Parida, Girish Kumar
    Panda, Raj Abhisek
    Agrawal, Kanhaiyalal
    NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (08) : 846 - 854
  • [32] Preoperative staging of clinically node-negative esophageal cancer by the combination of 18F-fluorodeoxyglucose positron emission tomography and computed tomography (FDG–PET/CT)
    Masahiko Yano
    Masaaki Motoori
    Koji Tanaka
    Kentaro Kishi
    Yoshiyuki Fujiwara
    Tatsushi Shingai
    Kunihito Gotoh
    Hidenori Takahashi
    Shingo Noura
    Terumasa Yamada
    Masayuki Ohue
    Hiroaki Ohigashi
    Osamu Ishikawa
    Esophagus, 2012, 9 : 210 - 216
  • [33] The influence of fluorine-18 fluorodeoxyglucose positron emission tomography (PET) on the clinical management of patients with head and neck cancer
    McCammon, R.
    Furuya, C.
    Raben, D.
    Song, J.
    Kane, M.
    Gaspar, L.
    Chen, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S184 - S185
  • [34] PET/CT versus contrast-enhanced computed tomography (ceCT) in staging non-Hodgkin lymphoma patients
    Gregianin, M.
    Dei Rossi, F.
    Cracco, E.
    Sancetta, R.
    Fraulini, C.
    Chisesi, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S163 - S164
  • [35] Integrated Fluorine-18 Fluorodeoxyglucose (18F-FDG) PET/CT Compared to Standard Contrast-Enhanced CT for Characterization and Staging of Pulmonary Tumors Eligible for Surgical Resection
    Quaia, E.
    Tona, G.
    Gelain, F.
    Lubin, E.
    Pizzolato, R.
    Boscolo, E.
    Bussoli, L.
    ACTA RADIOLOGICA, 2008, 49 (09) : 995 - 1004
  • [36] 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) staging of esophageal cancer
    Jager, P. L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 37 - 37
  • [37] Variability in the amount of fluorine-18 fluorodeoxyglucose excreted in urine measured from oncology patients during PET/computed tomography imaging
    Soliman, Khaled
    Alenezi, Ahmed
    Alqahtani, Saad
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (09) : 992 - 996
  • [38] Role of Fluorine-18 fluorodeoxyglucose PET/CT in post-surgery surveillance of uterine sarcoma
    Althaf, K. M.
    Kumar, Rakesh
    Sharma, Akshima
    Arunraj, Sreedharan
    Khan, Dikhra
    Shankar, Kritin
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [39] Assessment of Therapy Response by Fluorine-18 Fluorodeoxyglucose PET in Infection and Inflammation
    Kumar, Rakesh
    Chauhan, Anil
    Zhuang, Hongming
    Alavi, Abass
    PET CLINICS, 2006, 1 (02) : 191 - +
  • [40] Potential role of positron emission tomography/computed tomography with fluorodeoxyglucose (18F-FDG PET/CT) in the initial staging of breast cancer
    Sanchez, Rocio
    Jimenez, Antonio Daniel Gonzalez
    Luquin, Tariq Aroui
    Arnau, Inmaculada Mendoza
    Herrezuelo, Isabel Perez
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2025, 38 (01):
12345